Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats (Q48288448)

10 February 2018

title

Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats (English)

1 reference

10 February 2018

0 references

0 references

1

1 reference

10 February 2018

Marco A. Riva

6

1 reference

10 February 2018

Judith R. Homberg

5

object named as

Judith R Homberg

1 reference

10 February 2018

author name string

Sjoerd Hulsken

2

1 reference

10 February 2018

Greta Cazzaniga

3

1 reference

10 February 2018

Giorgio Racagni

4

1 reference

10 February 2018

publication date

20 November 2012

1 reference

10 February 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

10 February 2018

volume

16

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

1319-1330

1 reference

10 February 2018

Behavioural therapy based on distraction alleviates impaired fear extinction in male serotonin transporter knockout rats

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Antipsychotic drug actions on gene modulation and signaling mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Antistress properties of antidepressant drugs and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Altered expression and modulation of activity-regulated cytoskeletal associated protein (Arc) in serotonin transporter knockout rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Neuronal plasticity: a link between stress and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Neurons in medial prefrontal cortex signal memory for fear extinction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Preliminary evidence of the short allele of the serotonin transporter gene predicting poor response to cognitive behavior therapy in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Spatial segregation of BDNF transcripts enables BDNF to differentially shape distinct dendritic compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Therapeutic potential of new second generation antipsychotics for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

The GABAergic deficit hypothesis of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Activity-dependent regulation of inhibitory synapse development by Npas4

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Review of pharmacological treatment in mood disorders and future directions for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Regulation of brain-derived neurotrophic factor exon IV transcription through calcium responsive elements in cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Distinct 3'UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

The novel antipsychotic drug lurasidone enhances N-methyl-D-aspartate receptor-mediated synaptic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Serotonin transporter genotype x construction stress interaction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

A mixed polyunsaturated fatty acid diet normalizes hippocampal neurogenesis and reduces anxiety in serotonin transporter knockout rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Corticosterone actions on the hippocampal brain-derived neurotrophic factor expression are mediated by exon IV promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Selective modulation of fibroblast growth factor-2 expression in the rat brain by the atypical antipsychotic clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Prefrontal involvement in the regulation of emotion: convergence of rat and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Stress, depression, and neuroplasticity: a convergence of mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Utility of atypical antipsychotics in the treatment of resistant unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Induction of fear extinction with hippocampal-infralimbic BDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

The use of cognitive enhancers in animal models of fear extinction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

inferred from DOI database lookup

7 January 2021

based on heuristic

Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

inferred from DOI database lookup

7 January 2021

based on heuristic

Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001332

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S1461145712001332

1 reference

10 February 2018

release_eely3nklwfakxabktx7xv7ige4

Fatcat ID

0 references

1 reference

10 February 2018